Objectives

After participating in this educational activity, attendees should be able to:
1|Explain the difference in peri-intubation morbidity as it relates to the use of etomidate and ketamine.
2|Discuss the use of etomidate and ketamine as general anesthetic induction agents. 
3|Describe the current mainstay of therapy for coagulopathic bleeding.
4|Summarize the indications for prothrombin complex concentrate.
 

Presenter(s): 
Michael Chalifoux, M.D.
Division Chief, Thoracic Anesthesia
Department of Anesthesiology
Assistant Professor of Anesthesiology
UMass Chan Medical School - Baystate Medical Center

Ram Matsa, M.D.
Anesthesiologist
Department of Anesthesiology
UMass Chan Medical School - Baystate Medical Center

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Michael Chalifoux, MDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNot Applicable
Ram Matsa, M.D.Speaker/AuthorNo relevant relationships with ineligible companies to discloseNot Applicable
Session date: 
01/22/2026 - 7:00am to 8:00am EST
Location: 
Baystate Medical Center
759 Chestnut Street
Chicopee Agawam Conference Room
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.